EMD-34222
SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 2)
EMD-34222
Single-particle3.15 Å
Deposition: 05/09/2022Map released: 26/10/2022
Last modified: 29/03/2023
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-COV-2 BA.2.75 spike glycoprotein
Deposition Authors: Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
Sample: SARS-COV-2 BA.2.75 spike glycoprotein
Deposition Authors: Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.
Saito A 
,
Tamura T ,
Zahradnik J,
Deguchi S,
Tabata K ,
Anraku Y,
Kimura I,
Ito J,
Yamasoba D,
Nasser H,
Toyoda M,
Nagata K,
Uriu K,
Kosugi Y,
Fujita S ,
Shofa M ,
Monira Begum M,
Shimizu R,
Oda Y,
Suzuki R,
Ito H,
Nao N,
Wang L,
Tsuda M,
Yoshimatsu K,
Kuramochi J,
Kita S,
Sasaki-Tabata K,
Fukuhara H,
Maenaka K,
Yamamoto Y,
Nagamoto T,
Asakura H,
Nagashima M,
Sadamasu K,
Yoshimura K,
Ueno T ,
Schreiber G,
Takaori-Kondo A,
Shirakawa K,
Sawa H ,
Irie T,
Hashiguchi T,
Takayama K,
Matsuno K ,
Tanaka S,
Ikeda T,
Fukuhara T ,
Sato K
(2022) Cell Host Microbe , 30 , 1540 - 1555.e15
,
Tamura T ,
Zahradnik J,
Deguchi S,
Tabata K ,
Anraku Y,
Kimura I,
Ito J,
Yamasoba D,
Nasser H,
Toyoda M,
Nagata K,
Uriu K,
Kosugi Y,
Fujita S ,
Shofa M ,
Monira Begum M,
Shimizu R,
Oda Y,
Suzuki R,
Ito H,
Nao N,
Wang L,
Tsuda M,
Yoshimatsu K,
Kuramochi J,
Kita S,
Sasaki-Tabata K,
Fukuhara H,
Maenaka K,
Yamamoto Y,
Nagamoto T,
Asakura H,
Nagashima M,
Sadamasu K,
Yoshimura K,
Ueno T ,
Schreiber G,
Takaori-Kondo A,
Shirakawa K,
Sawa H ,
Irie T,
Hashiguchi T,
Takayama K,
Matsuno K ,
Tanaka S,
Ikeda T,
Fukuhara T ,
Sato K
(2022) Cell Host Microbe , 30 , 1540 - 1555.e15